Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death

ConclusionNICM and ICM patients had a same rate of ICD therapy for primary prevention of SCD in everyday practice. But, ICM patients more often died of a non- cardiovascular cause of death.Clinical Trial RegistrationNCT 01992458.

https://academic.oup.com/europace/article/20/1/65/2897770?rss=1

Source: Europace - January 11, 2017 Category: Cardiology Source Type: research